Skip to main content
. 2020 Oct 20;11(42):3793–3799. doi: 10.18632/oncotarget.27770

Table 3. AR of selected grade 3-4 AEs.

Grade ≥ 3 AEs Fixed-effect AR, % (95% CI range) Random-effect AR, % (95% CI range) I2,%a P value
Fatigue 0.03 (0.01; 0.04) 0.03 (0.01; 0.04) 0 0.95
Asthenia 0.01 (0.00; 0.03) 0.01 (0.00; 0.05) 3 1
Nausea 0.02 (0.01; 0.04) 0.02 (0.01; 0.04) 0 1
Vomiting 0.01 (0; 0.002) 0.01 (0; 0.002) 0 0.94
Diarrhea 0.05 (0.03; 0.08) 0.04 (0.02; 0.09) 19 0.58
Weight loss 0.04 (0.02; 0.06) 0.04 (0.02; 0.06) 0 1
Decreased appetite 0.00 (0; 0.02) 0.00 (0; 0.02) 0 1
Stomatitis 0.02 (0.01; 0.04) 0.01 (0.00; 0.30) 90 0.04
Mucosal inflammation 0.02 (0.01; 0.04) 0.02 (0.01; 0.04) 0 1
Rash 0.10 (0.08; 0.13) 0.10 (0.08; 0.13) 0 0.84
Pruritus 0.01 (0; 0.02) 0.01 (0; 0.02) 0 1
Hyperglycemia 0.32 (0.28; 0.36) 0.28 (0.21; 0.37) 36 0.13
Arthralgia 0 (0; 0.32) 0 (0; 0.32) 0 1

*Percentage of variance between studies that is due to heterogeneity and not chance. Abbreviations: AEs, Adverse Events; AR, Absolute Risk; CI, Confidence Interval.